Current Clinical Trials

Learn More 


Non-viral precision T cell receptor replacement for personalized cell therapy

Read Here


New Infusion Center

Read More


UCI Alpha Clinic provides a centralized infrastructure to enhance cell and gene therapy clinical research and activities at UCI. The UCI Alpha Clinic:

  • Is part of California Institute for Regenerative Medicine (CIRM).
  • Promotes and facilitates scientific collaborations and interactions.
  • Provides centralized clinical research infrastructure support.
  • Accelerates the implementation of clinical research trials.
Stem Cell

Stem-cell therapy for Parkinson’s disease shows promise in early study

Study of dopamine-producing neural cells raises hope for patients, UCI Health expert says.

Claire Henchcliffe, MD, DPhil



Clinical trial targets antibodies to treat rare form of myasthenia gravis

“We are in the early stages, but our hope is to bring about improvement while limiting side effects and perhaps one day gain the ability to eliminate the disease,” says neurologist Dr. Ali Habib of a first-in-human clinical trial at the UCI Alpha Clinic for a rare form of myasthenia gravis.


UCI tests cell therapy for myasthenia gravis

UCI Health and the UCI Alpha Clinic are conducting a clinical trial of an investigational cell therapy in patients with generalized myasthenia gravis, a rare autoimmune disorder.



UCI Alpha Clinic

Gross Hall: A CIRM Institute

University of California, Irvine
845 Health Sciences Road
1001 Gross Hall
Irvine, CA 92697-1705

Phone: (949) 824-3990
Email: alphaclinic@uci.edu